Triage

Bering Secures FDA Clearance for AI-Based Chest X-Ray Triage Solution

Retrieved on: 
Wednesday, December 6, 2023

FDA 510(k) clearance for AI Radiology software product, targeting emergency cases found on chest X-Rays.

Key Points: 
  • FDA 510(k) clearance for AI Radiology software product, targeting emergency cases found on chest X-Rays.
  • Bering to accelerate business in the US market, leveraging new and existing partnerships
    LONDON, Dec. 6, 2023 /PRNewswire/ -- Bering Limited, a London-based medical AI company, today announced it received US Food and Drug Administration (FDA) 510(k) clearance for its AI-powered chest X-Ray triage solution, 'BraveCX'.
  • With the FDA clearance, the company is now able to commercially provide the AI solution to medical professionals and healthcare institutions in the US.
  • FDA clearance means BraveCX prioritises patient safety, whilst still delivering the most advanced Risk Stratification algorithms where they are needed the most."

New Study Underscores Need for Greater Objectivity and Speed in Sepsis Diagnosis and Triage

Retrieved on: 
Wednesday, December 6, 2023

SAN FRANCISCO, Dec. 6, 2023 /PRNewswire/ -- Cytovale® today announced the publication of a new peer-reviewed study that highlights the need for its IntelliSep® test. The study, published in "Journal of Personalized Medicine," examined healthcare provider assessments of patients' sepsis risk, which have implications on diagnosis and timely, appropriate care for this fast-moving, potentially deadly condition. The study also evaluated the impact of improved diagnostic tools, such as host response assays, in the emergency department (ED) to aid in the rapid diagnosis and risk stratification of those with suspected sepsis.

Key Points: 
  • The study, published in "Journal of Personalized Medicine," examined healthcare provider assessments of patients' sepsis risk, which have implications on diagnosis and timely, appropriate care for this fast-moving, potentially deadly condition.
  • About 80% of sepsis patients present to the ED , therefore there is a need for improved diagnostic tools , such as host response assays.
  • The study showed great potential for faster diagnosis, triage and treatment of sepsis when using host response assay tools, like the recently FDA-cleared IntelliSep test from Cytovale.
  • The case presentations and questions used in the study were developed by an independent steering committee, which also conducted the analysis.

Cisco Redefines Cybersecurity Defense with Powerful, Portfolio-Wide Artificial Intelligence Capabilities

Retrieved on: 
Tuesday, December 5, 2023

MELBOURNE, Australia, Dec. 5, 2023 /PRNewswire/ -- CISCO LIVE -- Cisco (NASDAQ: CSCO), the leader in enterprise networking and security, today unveiled the Cisco AI Assistant for Security. This marks a major step in making artificial intelligence (AI) pervasive in the Security Cloud, Cisco's unified, AI-driven, cross-domain security platform. The AI Assistant will help customers make informed decisions, augment their tool capabilities and automate complex tasks.

Key Points: 
  • The new Cisco AI Assistant for Security marks a major step in making artificial intelligence pervasive in the Security Cloud, Cisco's unified, AI-driven, cross-domain security platform.
  • MELBOURNE, Australia, Dec. 5, 2023 /PRNewswire/ -- CISCO LIVE -- Cisco (NASDAQ: CSCO), the leader in enterprise networking and security, today unveiled the Cisco AI Assistant for Security.
  • This marks a major step in making artificial intelligence (AI) pervasive in the Security Cloud, Cisco's unified, AI-driven, cross-domain security platform.
  • The AI Assistant will help customers make informed decisions, augment their tool capabilities and automate complex tasks.

Memora Health Named to the 2023 CB Insights' Digital Health 50 List

Retrieved on: 
Tuesday, December 5, 2023

SAN FRANCISCO, Dec. 5, 2023 /PRNewswire/ -- CB Insights today named Memora Health to its fifth-annual Digital Health 50 (formerly the Digital Health 150), showcasing the 50 most promising private digital health companies of 2023.

Key Points: 
  • SAN FRANCISCO, Dec. 5, 2023 /PRNewswire/ -- CB Insights today named Memora Health to its fifth-annual Digital Health 50 (formerly the Digital Health 150), showcasing the 50 most promising private digital health companies of 2023.
  • "We are thrilled to be included on CB Insights' Digital Health 50 list among other top companies who are delivering on the promise of new technologies like AI to transform care delivery," said Manav Sevak, co-founder and CEO of Memora Health.
  • "From bringing clinical trials to underserved populations to developing new drugs and therapies, this year's Digital Health 50 winners are transforming the future of healthcare," said Alex Lennox-Miller, CB Insights' Lead Healthcare Analyst.
  • The 2023 CB Insights Digital Health 50 honorees were selected from a pool of over 10,000 companies, including applicants and nominees.

Pharmacy Brands Canada unveils First Independent Pharmacist-Led Clinic Model

Retrieved on: 
Monday, December 4, 2023

EDMONTON, AB, Dec. 4, 2023 /CNW/ - Pharmacy Brands Canada, Canada's Fastest Growing Banner program, is proud to announce the launch of its new world class Pharmacist-Led Clinic model, located in Sherwood Park, Alberta.

Key Points: 
  • EDMONTON, AB, Dec. 4, 2023 /CNW/ - Pharmacy Brands Canada, Canada's Fastest Growing Banner program, is proud to announce the launch of its new world class Pharmacist-Led Clinic model, located in Sherwood Park, Alberta.
  • Says Jon Johnson, President, and CEO of Pharmacy Brands Canada.
  • Our Pharmacy Clinic model provides an innovative and modern model that supports pharmacists to offer additional health services to their communities.
  • Pharmacy Brands Canada is committed to providing its banner members with comprehensive clinical resources and support, enabling them to successfully launch Pharmacist-Led Clinics within their local communities.

SAS named a FRAML leader by Chartis

Retrieved on: 
Thursday, November 30, 2023

CARY, N.C., Nov. 30, 2023 /PRNewswire/ -- Lauding the AI and analytics giant's "in-depth analysis capabilities across all stages of the customer lifecycle," Chartis Research has declared SAS as a RiskTech Quadrant® Category Leader in FRAML Solutions. SAS scored "high" across all completeness of offering evaluation criteria and notably ranked best-in-class in the analytics and user interface (UI) criterion.

Key Points: 
  • "SAS is unique both in its market maturity and its approach," said Nick Vitchev, Research Director of Financial Crime and Fraud Markets at Chartis.
  • SAS was among 35 vendors whose combined fraud and anti-money laundering solutions were evaluated by Chartis in its quadrant report, FRAML Solutions, 2023: Market and Vendor Landscape.
  • SAS' cloud-native AI platform, SAS® Viya® , supports custom SAS models, consortium SAS models and open source models, such as those using R, Python and Lua.
  • (July 2023)
    The strength of SAS' capabilities in these and other risk, fraud and compliance technologies contributed to SAS' No.

Cisco Launches New Business Performance Insight and Visibility for Modern Applications on AWS

Retrieved on: 
Tuesday, November 28, 2023

LAS VEGAS, Nov. 28, 2023 /PRNewswire/ -- AWS re:Invent -- Cisco (NASDAQ: CSCO) today announced new business metrics in Cisco Cloud Observability. Powered by the Cisco Observability Platform to enhance business context for modern applications running on Amazon Web Services (AWS). This latest release also supports integration with AWS services and application performance monitoring (APM) correlation and provides end-to-end visibility into the performance of cloud native applications.   

Key Points: 
  • New business metrics for Cisco Cloud Observability enable customers to significantly enhance critical business context when observing the end-to-end flow of modern applications.
  • Cloud service expansion, based on customer feedback, enables Cisco to unite applications and business metrics with the AWS services that impact customers within business transactions.
  • LAS VEGAS, Nov. 28, 2023 /PRNewswire/ -- AWS re:Invent -- Cisco (NASDAQ: CSCO) today announced new business metrics in Cisco Cloud Observability.
  • Powered by the Cisco Observability Platform to enhance business context for modern applications running on Amazon Web Services (AWS).

Expanding Access to Healthcare: Holy Cross Health Opens New Primary Care Practice in Downtown Silver Spring

Retrieved on: 
Wednesday, November 22, 2023

SILVER SPRING, Md., Nov. 22, 2023 /PRNewswire-PRWeb/ -- Holy Cross Health, a leading healthcare provider, proudly announces the opening of its newest primary care practice in downtown Silver Spring. Strategically located within The Leggett, a new 15-story apartment community that offers affordable and market-rate housing to residents 62 and greater. This new practice marks the fourth Holy Cross Health Partners primary care location and includes dedicated space for health education and fitness classes.

Key Points: 
  • Holy Cross Health, a leading healthcare provider, proudly announces the opening of its newest primary care practice in downtown Silver Spring.
  • SILVER SPRING, Md., Nov. 22, 2023 /PRNewswire-PRWeb/ -- Holy Cross Health, a leading healthcare provider, proudly announces the opening of its newest primary care practice in downtown Silver Spring.
  • This new practice marks the fourth Holy Cross Health Partners primary care location and includes dedicated space for health education and fitness classes.
  • In addition to the Holy Cross Health Partners primary care practices, Holy Cross Health is proud to be the only health system in Montgomery County to operate its own safety-net health centers providing comprehensive primary care to uninsured patients.

Cybellum's Product Security Platform Achieves Mitre's CWE-Compatible Designation

Retrieved on: 
Wednesday, November 22, 2023

TEL AVIV, Israel, Nov. 22, 2023 /PRNewswire/ --  Cybellum, creators of the award-winning Product Security Platform, announced today that its Product Security Platform has been formally designated as "CWE-Compatible" by the MITRE Corporation's Common Weakness Enumeration (CWE) Compatibility and Effectiveness Program. The designation means that Chief Product Security Officers (CPSOs) and their teams are able to manage the vulnerabilities and associated risks identification posed to their connected devices within a globally trusted framework.

Key Points: 
  • TEL AVIV, Israel, Nov. 22, 2023 /PRNewswire/ -- Cybellum , creators of the award-winning Product Security Platform, announced today that its Product Security Platform has been formally designated as "CWE-Compatible" by the MITRE Corporation's Common Weakness Enumeration (CWE) Compatibility and Effectiveness Program.
  • The designation means that Chief Product Security Officers (CPSOs) and their teams are able to manage the vulnerabilities and associated risks identification posed to their connected devices within a globally trusted framework.
  • "Cybellum's Product Security Platform aligns security and compliance teams, developers, and executives around one source of security truth that they can all rely on for ongoing vulnerability monitoring and compliance with the ever-changing landscape of emerging regulations."
  • The collaborative nature of CWE ensures that it remains a dynamic and evolving resource that reflects the latest insights into product security.

Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances

Retrieved on: 
Wednesday, November 22, 2023

The US launch, which included its previously announced FDA cleared e-ASPECTS module, represents a comprehensive platform designed to support clinicians and their imaging-based treatment decisions at all points across the stroke pathway, from simple imaging to more advanced imaging.

Key Points: 
  • The US launch, which included its previously announced FDA cleared e-ASPECTS module, represents a comprehensive platform designed to support clinicians and their imaging-based treatment decisions at all points across the stroke pathway, from simple imaging to more advanced imaging.
  • Long established as a market leader in Europe and a pioneer in the development of innovative stroke AI solutions, the company will continue to introduce its transformative technology to more US stroke centers.
  • The recent FDA clearances included Brainomix 360 e-CTP and Brainomix 360 e-MRI, both software modules that can support thrombolysis and thrombectomy treatment decisions, particularly for late-window patients who present to hospital more than 6-12 hours after stroke onset.
  • Brainomix has established commercial operations in the US and will continue to expand as it rolls out its products across US hospital networks.